The U.S. Food and Drug Administration (FDA) approved the first oral SRT medication for Gaucher disease in 2003. The currently approved drugs, Cerdelga® (eliglustat) and Zavesca® (miglustat), act differently in the body and are only approved for use in certain patients. If you are eligible to receive SRT, a Gaucher specialist can help you identify which medication is right for you. (fb)

Emotional resilience – also called emotional agility – is the ability to bounce back emotionally from stressful situations. Everyone can be resilient, and there are skills and exercises you can use to foster that ability. (fb)